The long-term safety and efficacy of omalizumab, alongside promising phase 3 trial results that demonstrated the efficacy and ...
Oncology practices must address barriers related to technology and workflow to successfully implement a system to collect patient-reported outcomes, according to a viewpoint paper published in JAMA ...
Prevention of asthma and allergy (PANDA) at KPE Lung and Allergy – Björn Nordlund's research group
Asthma and allergic diseases can be prevented through early primary and secondary interventions. The PANDA research group aims to identify, develop, and evaluate person-centered interventions for ...
Astrasentan becomes the first and only endothelin A receptor antagonist to focus on proteinuria reduction in primary ...
The country’s rapid urban growth means it is suffering from numerous teething problems – how did authorities get it so wrong?
The RIFs at the CDC affect multiple divisions, including: ...
FDA aligned on plan to initiate parallel Phase 2 trials of rademikibart in patients with moderate-to-severe asthma or COPD experiencing an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback